Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

and partial onset seizures in adults with epilepsy. Keppra(R)injection is an alternative for adult patients when oral administration is temporarily not feasible.

Keppra(R) tablets and oral solution are associated with the occurrence of central nervous system adverse events including somnolence and fatigue, behavioral abnormalities, and coordination difficulties, as well as hematological abnormalities. In pediatric patients 4 -16 years of age experiencing partial onset seizures, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, accidental injury, hostility, nervousness and asthenia. In adults experiencing partial onset seizures, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, asthenia, infection and dizziness. In patients 12 years of age and older experiencing myoclonic seizures with JME, the most common adverse events associated with Keppra(R) in combination with other AEDs were somnolence, neck pain, and pharyngitis. In patients 6 years of age and older experiencing PGTC seizures with idiopathic generalized epilepsy, the most common adverse event associated with Keppra(R) in combination with other AEDs was nasopharyngitis.

The adverse events that result from Keppra(R) injection use for myoclonic seizures in JME and partial onset seizures in adults include all of those associated with Keppra(R) tablets and oral solution.

Dosing for all Keppra(R) formulations must be individualized according to the patient's renal function status.

About UCB

UCB, Brussels, Belgium (http://www.ucb-group.com) is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , ... July 28, 2015 , ... A skin cancer ... a national 2015 Power of A award for “helping to make the world a ... A Gold Award winner by the American Society of Association Executives. Power of A ...
(Date:7/28/2015)... Miami, Florida (PRWEB) , ... July 28, 2015 ... ... engineer of patented products, announces Shelled Out, a new household invention that makes ... to earn $253.4 billion by 2020,” says Scott Cooper, CEO and Creative Director ...
(Date:7/28/2015)... , ... July 28, 2015 , ... By 2016, the ... the ability to engage with customers on a highly personal basis, increasing customer loyalty. ... out on big growth opportunities or lose customers to more nimble competitors. , The ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today joined ... to learn more about the impact of U.S. collaborations with local partners under ... accelerating agricultural development as an engine of broad-based economic growth in the region. ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... studio to measure and produce health outcomes associated with its training methods. This ... on a small group pre-post study, conducted in early 2015, training yielded an ...
Breaking Medicine News(10 mins):Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7
... for the Disabled and American Red Cross Mile High Chapter will be hosting ... 19th at the Winter Park Resort in Winter Park, CO. Experience world class ... all levels of riders and hikers! Join this summer tradition with: , ... World Class Mountain Biking! , Fantastic Hiking! ...
... that slumber key to storing memories , WEDNESDAY, June ... that sleep is essential for long-term storage of memories. ... their awake experiences while asleep remember them less well ... the RIKEN-MIT Center for Neural Circuit Genetics at MITs ...
... is enough, study finds , WEDNESDAY, June 24 (HealthDay ... most children with newly diagnosed acute lymphoblastic leukemia, new ... Jude Children,s Research Hospital found that children who had ... fewer adverse events than those who, in the past, ...
... compared to those who got clot-busting treatment , ... Canadian study adds compelling support for current recommendations ... heart attacks should have artery-opening angioplasty as soon ... guideline recommendations," said Dr. Warren J. Cantor, an ...
... patients with the Anakam Identity Suite(R) , , ... Sharp HealthCare, San Diego County,s largest healthcare system, has ... for patients accessing Sharp,s new patient portal. Sharp ... the needs of its patient community by providing a ...
... 24 Validation and Compliance Institute (VCI), which provides ... industries, will offer a series of Dietary Supplement Good ... division of NSF International. , , ... GMP regulations for dietary supplements, which the US Food ...
Cached Medicine News:Health News:18th Annual Fat Tire Classic Benefiting the National Sports Center for the Disabled & the American Red Cross Mile High July 17th - 19th, 2009 2Health News:Sleep May Be Essential for Long-Term Memory 2Health News:For Kids With Leukemia, Radiation May Be Safe to Skip 2Health News:Quick Angioplasty Best After Heart Attacks 2Health News:Quick Angioplasty Best After Heart Attacks 3Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 2Health News:Sharp HealthCare and Anakam(R) Partner to Protect Patients' Health Information 3Health News:Validation & Compliance Institute, LLC, to Provide Dietary Supplement GMP Training for NSF International 2
(Date:7/28/2015)... Corporation (NYSE: EW ), the global leader in ... reported net income for the quarter ended June 30, 2015 ... net income on a non-GAAP basis was $124.4 million, ... diluted share in the prior year period. In the ... diluted share, which included a $750 million payment to ...
(Date:7/28/2015)... July 28, 2015   Regulus Therapeutics Inc . ... discovery and development of innovative medicines targeting microRNAs, today ... for the quarter ended June 30, 2015 on Tuesday, ... Regulus will host a conference call ... pm Eastern Daylight Time to discuss its second quarter ...
(Date:7/28/2015)... Scripts Holding Company (Nasdaq: ESRX ) announced 2015 ... of $600.1 million, or $0.88 per diluted share.  Adjusted ... were $1.44 for the second quarter. 1  ... are validating the need for size and scale," said ... matters most is how that size and scale is ...
Breaking Medicine Technology:Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12
... 1, 2011  Ceregene, Inc. reported today that it has ... a gene therapy product expressing the neurturin (NRTN) gene ... study enrolled 51 patients at 11 medical centers throughout ... vector intended to provide constant, sustained expression of neurturin ...
... Dec. 1, 2011 Reportlinker.com announces that ... in its catalogue: , The Outlook ... http://www.reportlinker.com/p0559149/The-Outlook-for-Medical-Devices-in-North-East-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_care ... Highly-detailed analysis providing comprehensive quarterly-updated reports ...
Cached Medicine Technology:Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease 2Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease 3Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease 4The Outlook for Medical Devices in North East Asia 2The Outlook for Medical Devices in North East Asia 3The Outlook for Medical Devices in North East Asia 4The Outlook for Medical Devices in North East Asia 5
The SE-9500 automated hematology analyzerprovides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
AcT 5diff OV enables low-volume labs to advance to 5-part differential analysis at an affordable price. This analyzer delivers accurate test results and a user-friendly software interface in a compac...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
... offers three-dimensional VCS technology, ... and efficiency in white ... analysis. With its reputation ... HmX is an affordable ...
Medicine Products: